Our client is looking to engage experts with insights on Liquid Biopsy Panel Pricing.
Through this engagement, they would like to speak with directors / lab directors (or similar positions) at large or small- to mid-size biopharma companies with interest or experience with liquid biopsy (LBx).
They are scheduling paid 60-minute consultations. They are looking to finish this project before June 30th 2022.
They are hoping to learn more about the following topics:
- Perception of and willingness-to-pay for a provided LBx assay product profile
- Value perceptions for biomolecular assays, including tissue vs. liquid
- Assay / vendor selection processes and criteria